Delivery Order SPE2DB22D3009-SPE2DB24FBC71
Award Date
8/11/24
Potential Completion Date
8/12/24
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RabAvert rabies vaccine with diluents. The contract has a ceiling value of $20,958.00 and an ultimate completion date of February 7, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $14,234.30 firm fixed-price contract is for the supply of RabAvert Rabies Vaccine with diluents. The contract has an ultimate completion date of February 10, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $7,528.17 firm-fixed-price contract is for the supply of RabAvert rabies vaccine with diluents. The order falls under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of pharmaceutical and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,516.40, is for the delivery of RabAvert rabies vaccine with diluents. The contract has a period of performance through February 13, 2025 and utilizes a firm fixed price pricing structure. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of the rabies vaccine product RabAvert with diluents. The contract has a total ceiling value of $1,930.30 and an ultimate completion date of June 26, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RabAvert rabies vaccine with diluents, with a ceiling value of $10,479.00 and a period of performance through March 28, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of RabAvert rabies vaccine with diluents, with a ceiling value of $12,272.24 and a completion date of June 10, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RabAvert rabies vaccine with diluents, with a ceiling value of $27,024.20 and a final completion date of February 6, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a leading global pharmaceutical distribution company, to supply RabAvert rabies vaccine with diluents. The contract has a ceiling value of $11,581.80 and a performance period through April 12, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of RABAVERT rabies vaccine with diluents. The contract has a period of performance through September 30, 2024 and a ceiling value of $33,832.46. It is a firm fixed price contract. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply a wide range of medical commodities, including prescription drugs, vaccines, and medical...